Carta científica
Experiencia clínica con lixisenatida en pacientes con diabetes tipo 2 y obesidad en consultas de atención especializada en Málaga
Lixisenatide clinical experience on patients with type 2 diabetes and obesity in endocrinology offices in Malaga
Leído
5282
Vecesse ha leído el artículo
880
Total PDF
4402
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 7 | 5 | 12 |
| 2025 11 | 24 | 19 | 43 |
| 2025 10 | 33 | 10 | 43 |
| 2025 9 | 48 | 13 | 61 |
| 2025 8 | 22 | 8 | 30 |
| 2025 7 | 63 | 5 | 68 |
| 2025 6 | 34 | 1 | 35 |
| 2025 5 | 43 | 2 | 45 |
| 2025 4 | 24 | 1 | 25 |
| 2025 3 | 27 | 6 | 33 |
| 2025 2 | 37 | 4 | 41 |
| 2025 1 | 77 | 2 | 79 |
| 2024 12 | 74 | 5 | 79 |
| 2024 11 | 34 | 5 | 39 |
| 2024 10 | 33 | 2 | 35 |
| 2024 9 | 37 | 3 | 40 |
| 2024 8 | 26 | 4 | 30 |
| 2024 7 | 36 | 5 | 41 |
| 2024 6 | 24 | 3 | 27 |
| 2024 5 | 19 | 4 | 23 |
| 2024 4 | 41 | 10 | 51 |
| 2024 3 | 25 | 6 | 31 |
| 2024 2 | 42 | 5 | 47 |
| 2024 1 | 24 | 5 | 29 |
| 2023 12 | 64 | 3 | 67 |
| 2023 11 | 30 | 14 | 44 |
| 2023 10 | 24 | 8 | 32 |
| 2023 9 | 13 | 0 | 13 |
| 2023 8 | 14 | 4 | 18 |
| 2023 7 | 18 | 5 | 23 |
| 2023 6 | 19 | 2 | 21 |
| 2023 5 | 17 | 7 | 24 |
| 2023 4 | 14 | 4 | 18 |
| 2023 3 | 10 | 5 | 15 |
| 2023 2 | 21 | 2 | 23 |
| 2022 1 | 29 | 8 | 37 |
| 2022 12 | 29 | 6 | 35 |
| 2022 11 | 32 | 12 | 44 |
| 2022 10 | 37 | 8 | 45 |
| 2022 9 | 37 | 11 | 48 |
| 2022 8 | 49 | 17 | 66 |
| 2022 7 | 37 | 10 | 47 |
| 2022 6 | 48 | 15 | 63 |
| 2022 5 | 31 | 6 | 37 |
| 2022 4 | 61 | 10 | 71 |
| 2022 3 | 88 | 5 | 93 |
| 2022 2 | 80 | 6 | 86 |
| 2021 1 | 61 | 7 | 68 |
| 2021 12 | 54 | 13 | 67 |
| 2021 11 | 73 | 7 | 80 |
| 2021 10 | 49 | 13 | 62 |
| 2021 9 | 46 | 16 | 62 |
| 2021 8 | 59 | 10 | 69 |
| 2021 7 | 50 | 5 | 55 |
| 2021 6 | 41 | 8 | 49 |
| 2021 5 | 66 | 10 | 76 |
| 2021 4 | 110 | 17 | 127 |
| 2021 3 | 73 | 11 | 84 |
| 2021 2 | 28 | 11 | 39 |
| 2020 1 | 55 | 9 | 64 |
| 2020 12 | 41 | 8 | 49 |
| 2020 11 | 67 | 4 | 71 |
| 2020 10 | 32 | 12 | 44 |
| 2020 9 | 58 | 8 | 66 |
| 2020 8 | 63 | 5 | 68 |
| 2020 7 | 50 | 14 | 64 |
| 2020 6 | 53 | 6 | 59 |
| 2020 5 | 44 | 12 | 56 |
| 2020 4 | 45 | 12 | 57 |
| 2020 3 | 48 | 10 | 58 |
| 2020 2 | 65 | 4 | 69 |
| 2020 1 | 42 | 7 | 49 |
| 2019 12 | 57 | 18 | 75 |
| 2019 11 | 29 | 3 | 32 |
| 2019 10 | 51 | 2 | 53 |
| 2019 9 | 52 | 14 | 66 |
| 2019 8 | 44 | 1 | 45 |
| 2019 7 | 43 | 17 | 60 |
| 2019 6 | 78 | 31 | 109 |
| 2019 5 | 179 | 9 | 188 |
| 2019 4 | 100 | 41 | 141 |
| 2019 3 | 24 | 15 | 39 |
| 2019 2 | 21 | 6 | 27 |
| 2019 1 | 16 | 4 | 20 |
| 2018 12 | 9 | 5 | 14 |
| 2018 11 | 16 | 3 | 19 |
| 2018 10 | 24 | 4 | 28 |
| 2018 9 | 10 | 3 | 13 |
| 2018 8 | 2 | 2 | 4 |
| 2018 7 | 14 | 2 | 16 |
| 2018 6 | 12 | 1 | 13 |
| 2018 5 | 5 | 1 | 6 |
| 2018 4 | 19 | 4 | 23 |
| 2018 3 | 32 | 1 | 33 |
| 2018 2 | 21 | 2 | 23 |
| 2018 1 | 7 | 6 | 13 |
| 2017 12 | 51 | 1 | 52 |
| 2017 11 | 11 | 1 | 12 |
| 2017 10 | 15 | 4 | 19 |
| 2017 9 | 5 | 1 | 6 |
| 2017 8 | 15 | 2 | 17 |
| 2017 7 | 13 | 2 | 15 |
| 2017 6 | 21 | 6 | 27 |
| 2017 5 | 16 | 5 | 21 |
| 2017 4 | 28 | 2 | 30 |
| 2017 3 | 22 | 13 | 35 |
| 2017 2 | 21 | 0 | 21 |
| 2016 1 | 12 | 1 | 13 |
| 2016 12 | 28 | 14 | 42 |
| 2016 11 | 23 | 7 | 30 |
| 2016 10 | 44 | 10 | 54 |
| 2016 9 | 57 | 11 | 68 |
| 2016 8 | 32 | 13 | 45 |
| 2016 7 | 30 | 5 | 35 |
| 2016 6 | 36 | 20 | 56 |
| 2016 5 | 2 | 4 | 6 |
| 2016 4 | 1 | 1 | 2 |
| 2016 3 | 0 | 2 | 2 |
| 2016 2 | 1 | 1 | 2 |
| 2015 1 | 1 | 1 | 2 |
| 2015 12 | 17 | 11 | 28 |
| 2015 11 | 6 | 7 | 13 |
Mostrar todo
